Role of oxidative stress and inflammation in type 1 Gaucher disease (GD1): Potential use of antioxidant/anti-inflammatory medications

被引：2
|
作者：
Kartha, Reena V. [1 ]
Joers, James [1 ]
Tuite, Paul [1 ]
Hovde, Laurie B. [1 ]
Mishra, Usha [1 ]
Rudser, Kyle [1 ]
Oz, Gulin [1 ]
Utz, Jeanine James [1 ]
Cloyd, James C. [1 ]
机构：
[1] Univ Minnesota, Minneapolis, MN USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2017年 / 120卷 / 1-2期
关键词：
D O I：
10.1016/j.ymgme.2016.11.175
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
166
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [1] Preliminary N-acetylcysteine results for LDN 6722-Role of oxidative stress and inflammation in Gaucher disease type 1: Potential use of antioxidant anti-inflammatory medications
    Kartha, Reena V.
    Joers, James
    Terluk, Marcia
    Tuite, Paul
    Mishra, Usha
    Rudser, Kyle
    Oz, Gulin
    Weinreb, Neal J.
    Jarnes-Utz, Jeanine
    Cloyd, James C.
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S82 - S82
  • [2] Demography of untreated Type 1 Gaucher disease (GD1) in children.
    Kaplan, P
    Andersson, HC
    Charrow, J
    Prakash-Cheng, A
    Kolodny, EH
    Mistry, P
    Pastores, GM
    Rosenbloom, B
    Scott, CR
    Wappner, RS
    Weinreb, N
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 456 - 456
  • [3] Population pharmacokinetics of eliglustat in patients with Gaucher Disease Type 1 (GD1)
    Lu, Qiang
    Gao, Yue
    Li, Jing
    Kanamaluru, Vanaja
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S127 - S128
  • [4] Occurrence of multiple cancers in type I Gaucher disease (GD1)
    Lo, Sarah
    Stein, Philip
    Yang, Ruhua
    Mistry, Pramod
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (02) : S25 - S25
  • [5] Post-marketing surveillance of miglustat in type 1 Gaucher disease (GD1)
    Hughes, D. A.
    Hollak, C. E. M.
    Schwierin, B.
    Bembi, B.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 119 - 119
  • [6] Blood and brain biomarkers of oxidative stress and inflammation in type 1 Gaucher disease: Effect of antioxidant therapy
    Kartha, Reena V.
    Joers, James
    Terluk, Marcia
    Tuite, Paul
    Mishra, Usha
    Rudser, Kyle
    Oz, Gulin
    Utz, Jeanine Jarnes
    Cloyd, James C.
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S74 - S75
  • [7] Evaluation of glucosylsphingosine as a biomarker of the eliglustat treatment response in patients with Gaucher disease type 1 (GD1)
    Peterschmitt, M. Judith
    Zhang, Kate
    Liu, Lin
    Cox, Gerald F.
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S94 - S95
  • [8] Prevalence of polyneuropathy in adult type 1 Gaucher disease (GD1): A multinational prospective observational study
    Hollak, C. E. M.
    Biegstraaten, M.
    Van Schaik, I. N.
    Mengel, E.
    Marodi, L.
    Petakov, M.
    Niederau, C.
    Giraldo, P.
    Hughes, D.
    Mrsic, M.
    Mehta, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 107 - 107
  • [9] Clinical benefits of miglustat on bone disease in adult type 1 Gaucher disease (GD1): A meta-analysis
    Pastores, G. M.
    Elstein, D.
    Hrebicek, M.
    Zimran, A.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S68 - S68
  • [10] Antioxidant and anti-inflammatory activities of Geranium ayavacense:: Role in oxidative stress
    Okuhama, N
    Babar, S
    Melchor, V
    Miller, MJS
    Sandoval, M
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S337 - S337
12345